bioAffinity Technologies
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. bioAffinity Technologies's past years’ income statements indicate that its last revenue has increased compared to the previous period by 52627% to $2,532,499. The net income raised on -$7,937,011 and profit margin reached -313%. Total operating expenses were $8,764,843.

Profit Margin

bioAffinity Technologies, Inc. (NASDAQ:BIAF): Profit margin
2019 0 -3.30M
2020 0 -7.26M
2021 0 -6.32M
2022 4.80K -8.15M -169771.25%
2023 2.53M -7.93M -313.41%

BIAF Income Statement (2019 – 2023)

2023 2022 2021 2020 2019
Revenue
Revenue
2.53M4.80K000
Cost of revenue
1.74M4674.81K22.24K40.27K
Gross profit
791.61K4.33K-4.81K-22.24K-40.27K
Operating exp.
Research and development
1.72M1.28M1.32M1.61M1.85M
Selling and marketing
00000
Total operating expenses
8.76M4.01M2.20M2.60M3.05M
Operating income
-7.97M-4.01M-2.20M-2.60M-3.09M
Other income (expenses), net
57.21K-4.14M-4.11M-4.66M-212.05K
Income before tax
-7.91M-8.15M-6.32M-7.26M-3.30M
Income tax expense
20.99K2.45K1.95K2.75K3.2K
Net income
-7.93M-8.15M-6.32M-7.26M-3.30M
Earnings per share
Basic EPS
-0.91-1.81-0.86-0.99-0.45
Diluted EPS
-0.91-1.81-0.86-0.99-0.45
Data sourceData source